Press release Archives

11/10/2022

7 min read

Inceptua Early Access and Sentynl Therapeutics Inc. Announce the Launch of the Early Access Program for Nulibry® (fosdenopterin)

Inceptua Early Access and Sentynl Therapeutics Inc. Announce...

Featured Press release

15/08/2022

8 min read

Apealea® (paclitaxel micellar) is now available in Germany for the treatment of ovarian cancer

Apealea® (paclitaxel micellar) is now available in Germany...

Featured Inceptua Pharma Press release

01/04/2022

4 min read

Vice President, Global Regulatory Affairs Joins Inceptua Early Access

Vice President, Global Regulatory Affairs Joins Inceptua Early...

Featured Press release

13/01/2022

4 min read

World-Leading Regulatory Affairs Expert Joins Inceptua Group

World-Leading Regulatory Affairs Expert Joins Inceptua Group Luxembourg,...

Featured Press release

10/12/2021

9 min read

Inceptua receives approval of marketing authorization transfer of Apealea® (paclitaxel micellar) for the treatment of ovarian cancer

European Commission and MHRA approves transfer of marketing...

Featured Inceptua Pharma Press release

10/11/2021

3 min read

Scott Forde joins Inceptua as Senior Director, Business Development.

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Early Access Featured Press release

05/10/2021

4 min read

Inceptua strengthens early access division with key business development hire

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Early Access Featured Press release

28/12/2020

2 min read

Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Featured Inceptua Pharma Press release

03/12/2020

5 min read

Inceptua Partners with Global Blood Therapeutics for an Early Access Program for Voxelotor for Patients with Sickle Cell Disease

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Featured Press release

25/09/2020

5 min read

Inceptua receives approval of marketing authorization transfer of Jetrea® (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Featured Press release

Posted by Inceptua

26/06/2020

4 min read

Inceptua Group Announces Partnership with BioCryst on Expanded Access Program for Patients with Hereditary Angioedema

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Featured Press release

23/03/2020

5 min read

Global License Agreement a Building Block in Strategic Growth Plans

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Featured Press release

13/03/2020

2 min read

Oxurion and Inceptua Group enter global license agreement for the commercialization of JETREA®

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Featured Press release

07/02/2020

4 min read

Inceptua and Portola enter exclusive distribution agreement for Ondexxya®

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Featured Press release

05/02/2020

5 min read

Inceptua appoints new Head of Asia-Pacific, Clinical Trial Services

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Featured Press release

06/12/2019

14 min read

Inceptua and Onconova Therapeutics Announce Pre-approval Access Collaboration for Rigosertib in Selected Countries Outside the US

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Press release

Press release

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.